Dr Freitag has 20 years of experience in the pharmaceutical industry with positions in companies including Hoffmann La Roche, Shire, and BTG, where he led global clinical development projects. He held the position of Chief Medical Officer at Dynacure and Azafaros, where he was responsible for medical and regulatory strategy, including clinical development of a rare diseases compound. Dr Freitag was the Medical Monitor on NUZ’s Phase 1 MEND study and oversaw medical and clinical activities.
